Pelthos Therapeutics Inc., 2025-11-19
An SEC Form D private-offering notice from Durham, NC, a $18,000,000 filer-stated offering target in Biotech. Filed 2025-11-19. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
Bio-pharmaceutical company commercializing FDA-approved dermatology treatments, including ZELSUVMI for molluscum contagiosum, formed via Ligand Pharmaceuticals' combination with Channel Therapeutics.
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Ohanafy, Inc., 2025-11-26, $5M, Wilmington, NC
- Conexeu Sciences Inc., 2025-11-20, $202K, Reno, NV
- Futureproof Ops, Inc, 2025-11-24, $25K, Holly Springs, NC
- ECLIPSE BIOINNOVATIONS, INC., 2025-11-20, $7.2M, San Diego, CA
- Siftwell Analytics, Inc., 2025-11-19, $3.5M, Charlotte, NC
- Solarea Bio, Inc., 2025-11-20, Waltham, MA
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.